In Brief: FDA OTC staff changes
This article was originally published in The Tan Sheet
Executive Summary
FDA OTC staff changes: Mary Jane Walling joins Office of OTC Drug Evaluation as associate director for regulatory information, reporting to Director Michael Weintraub, MD. Walling was previously with the agency's Center for Biologics Evaluation and Research as associate director for regulatory policy in the Office of Establishment Licensing and Product Surveillance. Separately, OTC Medical Reviewer Man Fung, MD, has left the agency to join the University of Pennsylvania Medical Center to work in cancer research...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning